Month: February 2023

Genius Brands to Release First AI Generated Children’s Series Utilizing Artificial Intelligence Tools, Including OpenAI’s ChatGPT

Written by Customer Service on February 13, 2023. Posted in Public Companies.

“Kidaverse Fast Facts” to Debut Across Genius Networks’ Platforms in March 2023 Use of AI tools provides Genius Brands with Low Cost Production Opportunities and Content Expansion Initiatives“Kidaverse Fast Facts” to Debut Across Genius Networks’ Platforms in March 2023Use of AI tools provides Genius Brands with Low Cost Production Opportunities and Content Expansion Initiatives BEVERLY HILLS, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) — Genius Brands International (“Genius Brands”) (NASDAQ: GNUS) today announced the launch of its first AI-generated children’s series, Kidaverse Fast Facts, utilizing OpenAI’s ChatGPT, among other AI technologies. The series will include new and exclusive shorts and will first premiere in March across Genius Networks’ YouTube and social channels, and then broaden its footprint...

Top Ships Inc. Announces New Time Charter Employment at Very Strong Rate and Updated Revenue Backlog of $280 Million

Written by Customer Service on February 13, 2023. Posted in Public Companies.

ATHENS, Greece, Feb. 13, 2023 (GLOBE NEWSWIRE) — TOP Ships Inc. (NASDAQ: TOPS) (the “Company”), an international owner and operator of modern, fuel efficient “ECO” tanker vessels, announced today that it has entered into a time charter employment contract with a high-quality counterparty for its product/chemical tanker M/T Eco Marina Del Rey. The new time charter will commence immediately after the expiry of the present time charter employment contract in the 1st quarter of 2024 and will have a firm duration of 3 years with an additional year at the charterer’s option. The revenue backlog expected to be generated by this fixture is about $22.4 million for the firm period and about $30.6 million if the charterer exercises the option to extend for one additional year. Evangelos Pistiolis, the President, Chief Executive...

CEMATRIX Announces $5.3 Million in New Contracts

Written by Customer Service on February 13, 2023. Posted in Public Companies.

Signed 2023 Contracts Total $29 Million To Date CALGARY, Alberta, Feb. 13, 2023 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company”) a North American leading manufacturer and supplier of technologically advanced cellular concrete products announced that its wholly owned operating subsidiaries, which include CEMATRIX (Canada) Inc. (“CCI”), MixOnSite USA Inc. (“MOS”) and Pacific International Grout Company (“PIGCO’) have executed $5.3 million in new contracts. Factoring in the $5.3 million in contracts executed, converted contracts, the new net contracts in process of $1.5 million and sales completed to the end of 2022, the Corporation’s backlog has increased to $86.4 million, a 9% increase compared to CEMATRIX’s sales adjusted backlog of $79.5 million at December 31, 2022. $40.9 million...

Coherus Granted Permanent, Product-Specific Q-Code for CIMERLI® (ranibizumab-eqrn) from the Centers for Medicare and Medicaid Services

Written by Customer Service on February 13, 2023. Posted in Public Companies.

– Q-Code assigned to CIMERLI® for Medicare claims processing effective for dates of service on and after April 1, 2023 – – COHERUS Solutions™ patient services hub is available to facilitate successful access and reimbursement – REDWOOD CITY, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced that the Centers for Medicare and Medicaid Services (CMS) has published a new code pursuant to the Company’s application for Healthcare Common Procedure Coding System (HCPCS) Q-codes. The HCPCS Q-code assigned to CIMERLI® will be effective for patients administered CIMERLI® on or after April 1, 2023. Paul Reider, Chief Commercial Officer of Coherus, said, “This is an important milestone in the CIMERLI® launch. Beginning April 1st, use of CIMERLI’s...

Dental Endoscopes Market is Predicted to Garner a Revenue of USD 1,200.00 Million by Growing with a CAGR of 11.7% During 2022-2028; Growing Demand for Advanced Dental Diagnosis and Therapy Evaluation to Accelerate Market Growth – SkyQuest

Written by Customer Service on February 13, 2023. Posted in Mergers And Acquisitions.

The most recent study conducted by SkyQuest on the dental endoscopes market is based on the compilation, evaluation, and interpretation of information from reliable and highly trustworthy sources. The primary goals of the study report are to forecast the trends that will be popular in the upcoming years as well as to estimate the sizes of the major categories and areas. For the purpose of determining the company scope, the study report also includes qualitative and quantitative data for each key regional market. Westford, USA, Feb. 13, 2023 (GLOBE NEWSWIRE) — The dental endoscopes market in the North America region to gain the highest market share during the projected time frame. On the basis of the rising aging population and the rising frequency of dental implants, the market is anticipated to experience notable expansion. The...

EuroDry Ltd. Reports Results for the Year and Quarter Ended December 31, 2022

Written by Customer Service on February 13, 2023. Posted in Earnings Releases And Operating Results.

ATHENS, Greece, Feb. 13, 2023 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three and twelve-month periods ended December 31, 2022. Fourth Quarter 2022 Highlights:Total net revenues of $15.1 million.Net income attributable to common shareholders of $6.3 million or $2.21 and $2.20 earnings per share basic and diluted, respectively.Adjusted net income attributable to common shareholders1 for the quarter of $3.3 million, or, $1.18 per share basic and diluted, respectively.Adjusted EBITDA1 was $7.3 million.An average of 10.1 vessels were owned and operated during the fourth quarter of 2022 earning an average time charter equivalent rate of $16,689 per day....

San Cristobal Mining Inc. Completes Acquisition of Minera San Cristobal S.A.

Written by Customer Service on February 13, 2023. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) — San Cristobal Mining Inc. (“San Cristobal Mining” or “SCM” or the “Company”) is pleased to announce that it has completed the acquisition of Minera San Cristóbal S.A. (“MSC”) and all of its associated assets from Sumitomo Corporation (“Sumitomo”) under the terms of a stock purchase agreement pursuant to which the Company acquired all the issued and outstanding shares of Comercial Metales Blancos AB, SC Minerals Bolivia S.R.L., former subsidiaries of Sumitomo which hold all of the equity interests in MSC (the “Transaction“). Quinton Hennigh, President and Director of San Cristobal Mining, stated: “We are excited to complete our acquisition of Minera San Cristóbal S.A. and all of its associated assets and subsidiaries, bringing San Cristobal Mining into the...

Aleafia Health Announces Q3 FY2023 Results, International Expansion and Second Quarter of Profitability

Written by Customer Service on February 13, 2023. Posted in Earnings Releases And Operating Results.

2nd consecutive quarter of positive Adjusted EBITDA1 4% Adjusted EBITDA margin2 places company in top 3 position for profitability amongst its peers3 9% growth in adult use revenue4 over prior quarter; 5% growth in adult-use revenue5year over year 40% increase in medical net revenue6 with $1.1 million record month revenue in November 2022 1st shipment made toward new European agreement announced in Q2 FY2023 Estimated $1 million sales7 contract to second European partner Gross profit before fair value adjustments of 37% versus 27% in the prior year8TORONTO, Feb. 13, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to report its financial results for the three months ended December 31, 2022, its third quarter of its fiscal year ending March 31, 2023 (“FY2023”). For...

mdf commerce reports Third Quarter of Fiscal 2023 Financial Results

Written by Customer Service on February 13, 2023. Posted in Earnings Releases And Operating Results.

Q3 FY2023 total revenue of $31.7 million grew by 3.3% compared to $30.7 million in Q3 FY2022 Recurring Revenue (1)of $24.7 million in Q3 FY2023 compared to $25.0 million in Q3 FY2022 Adjusted EBITDA(2) of $0.9 million for Q3 FY2023 compared to $0.7 million in Q3 FY2022 Sale of InterTrade subsidiary for cash proceeds of $65.8 million and repayment of the majority of long-term debtMONTREAL, Feb. 13, 2023 (GLOBE NEWSWIRE) — mdf commerce inc. (the “Corporation”) (TSX:MDF), a SaaS leader in digital commerce technologies, reported third quarter financial results for the three-month period ended December 31, 2022 (Q3 FY2023). Financial references are expressed in Canadian dollars unless otherwise indicated. “This third quarter of fiscal 2023 represents a second consecutive quarter with a positive adjusted EBITDA(2). In response to...

Pyxis Oncology to Participate in the Virtual 2023 SVB Securities Global Biopharma Conference

Written by Customer Service on February 13, 2023. Posted in Public Companies.

CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, Pamela Connealy, Chief Financial Officer, Jay Feingold, M.D., Ph.D., Chief Medical Officer, and Jan Pinkas, Ph.D., Chief Scientific Officer, will host investor meetings on February 15, 2023 as part of the SVB Securities Global Biopharma Conference, taking place virtually. Institutional investors interested in meeting with management during the conference may reach out to their SVB Securities representative or Jennifer Davis Ruff, Investor Relations for Pyxis Oncology, at jdavisruff@pyxisoncology.com. About Pyxis Oncology, Inc.Pyxis Oncology,...

Month: February 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals